Drug Delivery Systems for Metabolic Disorders

Dureja, H; Murthy, NN; Wich, PR; Dua, K

Drug Delivery Systems for Metabolic Disorders

Dureja, H Murthy, NN Wich, PR Dua, K

Permalink

Publisher:: Elsevier
Publication Type:: Book
Citation:: 2022, pp. 1-505
Issue Date:: 2022-01-01

Closed Access

	Filename	Description	Size
	Murthy-DDS-1633219.PDF	Published version	10.92 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Dureja, H
dc.contributor.author	Murthy, NN
dc.contributor.author	Wich, PR
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.date.accessioned	2023-02-18T14:00:52Z
dc.date.available	2023-02-18T14:00:52Z
dc.date.issued	2022-01-01
dc.identifier.citation	2022, pp. 1-505
dc.identifier.isbn	9780323996334
dc.identifier.uri	http://hdl.handle.net/10453/166246
dc.description.abstract	Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics. Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases.
dc.language	en
dc.publisher	Elsevier
dc.relation.isbasedon	10.1016/C2021-0-01991-X
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Drug Delivery Systems for Metabolic Disorders
dc.type	Book
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy
utslib.copyright.status	closed_access	*
dc.date.updated	2023-02-18T14:00:46Z
pubs.publication-status	Published

Abstract:

Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug delivery systems in various metabolic disorders, including disturbances in protein, lipid, carbohydrate and hormone metabolism and lysosomal and mitochondrial disorders. It provides a brief introduction to metabolic disorders, along with a focus on the current landscape and trends in understanding disease pathology using different in vitro and in vivo models required for clinical applications and developments of new therapeutics. Each subsequent chapter covers drug delivery systems dedicated to metabolic diseases caused by disturbances in protein, lipid, carbohydrate and hormone metabolism. Then, it moves on to cover lysosomal storage disorders and applications of phytopharmaceuticals in this context. This is the perfect reference for researchers in pharmaceutical science who are interested in developing new treatments for metabolic diseases.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/166246